Twelve Leads Electrocardiographic Expressions at Different Body Positioning
1 other identifier
observational
50
1 country
1
Brief Summary
Electrical conduction in the heart produces a heartbeat; electrical signals are sent to the heart muscle upon each contraction, causing the heart to pump blood. These electrical impulses are recorded by an electrocardiogram (ECG), which makes it possible to evaluate electrical conduction and cardiac rhythm. ECG is a non-invasive technique used to assess pacemaker function and perioperative heart health. Ten electrodes are used in the 12-lead ECG, the gold standard for diagnosing cardiac illness and anatomy, to record the electrical activity of the heart from various perspectives. With wireless data transmission to the cloud, this technology is now included into emergency and ambulance situations, streamlining processes and improving signal quality. The purpose of this observational study is to examine 12-lead electrocardiogram data for better clinical application and diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2024
CompletedFirst Posted
Study publicly available on registry
October 21, 2024
CompletedStudy Start
First participant enrolled
October 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedOctober 21, 2024
August 1, 2024
2 months
September 25, 2024
October 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ECG change related to position
ECG ST segment elevation or depression might be attributed to varying body postures. The ST segments\' change to baseline will be compared by the investigators.
through study completion, an average of 30 minutes.
Eligibility Criteria
Participants without diagnosed arrhythmia, ischemic heart disease, congestive heart failure or pending for all kinds of heart surgery.
You may qualify if:
- Adults 18\~65 years of age
- Fluent in either Taiwanese/Chinese/English.
You may not qualify if:
- Pregnancy
- Refusal to give informed consent
- Candidate for coronary bypass surgery or valves surgery or other cardiac surgery
- Participants with diagnosed arrhythmia, ischemic heart disease or congestive heart failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Sanmin Dist, 80756, Taiwan
Study Officials
- STUDY DIRECTOR
Tzu-Ying Li
Kaohsiung Medical University Chung-Ho Memorial Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2024
First Posted
October 21, 2024
Study Start
October 31, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
October 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 3 months and ending 1 year after the publication of results
- Access Criteria
- Researchers with formal inquiry will be able to access it.
Statistical Analysis Plan can be shared